These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22996140)

  • 1. Lipid solubility of warfarin may contribute to warfarin resistance in patients receiving total parenteral nutrition.
    McAllister RK; Weinberg GL
    Am J Med Sci; 2012 Oct; 344(4):340. PubMed ID: 22996140
    [No Abstract]   [Full Text] [Related]  

  • 2. Warfarin resistance associated with parenteral nutrition.
    Cheung LK; Agi R; Hyman DJ
    Am J Med Sci; 2012 Mar; 343(3):255-8. PubMed ID: 22143126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition.
    Dickerson RN; Garmon WM; Kuhl DA; Minard G; Brown RO
    Pharmacotherapy; 2008 Mar; 28(3):308-13. PubMed ID: 18294110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.
    Crowther MA; Ageno W; Schnurr T; Manfredi E; Kinnon K; Garcia D; Douketis JD
    Haematologica; 2005 Jan; 90(1):137-9. PubMed ID: 15642685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of coagulation abnormalities in hospitalized patients receiving lipid-based parenteral nutrition.
    Duerksen DR; Papineau N
    JPEN J Parenter Enteral Nutr; 2004; 28(1):30-3. PubMed ID: 14763791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on possible effects of daily vitamin K replacement, especially upon warfarin therapy.
    Bern M
    JPEN J Parenter Enteral Nutr; 2004; 28(6):388-98. PubMed ID: 15568285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher vitamin K intake is associated with better INR control and a decreased need for INR tests in long-term warfarin therapy.
    Leblanc C; Presse N; Lalonde G; Dumas S; Ferland G
    Thromb Res; 2014 Jul; 134(1):210-2. PubMed ID: 24824293
    [No Abstract]   [Full Text] [Related]  

  • 8. Achievement of therapeutic international normalized ratio following adjustment of tube feeds.
    Krajewski KC; Butterfoss K
    J Clin Pharmacol; 2011 Mar; 51(3):440-3. PubMed ID: 20538908
    [No Abstract]   [Full Text] [Related]  

  • 9. Central venous thrombosis in patients receiving long-term parenteral nutrition.
    Duerksen DR
    Appl Physiol Nutr Metab; 2008 Feb; 33(1):32-8. PubMed ID: 18347651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K in anticoagulation therapy.
    Hanslik T; Viboud C; Chadenat ML; Jubault V; Prinseau J
    Lancet; 2001 Feb; 357(9256):637; author reply 638. PubMed ID: 11558516
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between dietary vitamin K intake and the stability of anticoagulation effect in patients taking long-term warfarin.
    Kim KH; Choi WS; Lee JH; Lee H; Yang DH; Chae SC
    Thromb Haemost; 2010 Oct; 104(4):755-9. PubMed ID: 20664899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K supplementation during oral anticoagulation: concerns.
    Stafford DW; Roberts HR; Vermeer C
    Blood; 2007 Apr; 109(8):3607; author reply 3607-8. PubMed ID: 17409344
    [No Abstract]   [Full Text] [Related]  

  • 13. Urgent warfarin reversal: know your options.
    Pendergrast J
    Can J Anaesth; 2010 May; 57(5):395-401. PubMed ID: 20177848
    [No Abstract]   [Full Text] [Related]  

  • 14. Warfarin, short bowel syndrome, and intravenous lipids.
    Lutomski DM
    Pharmacotherapy; 1998; 18(6):1375-6. PubMed ID: 9855342
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated international normalized ratio from vitamin K supplement discontinuation.
    Miesner AR; Sullivan TS
    Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment: Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets.
    Kalvass JC; Phinney SD; Vernon MC; Rosedale R; Westman EC
    Ann Pharmacother; 2005; 39(7-8):1371-2; author reply 1372. PubMed ID: 15928257
    [No Abstract]   [Full Text] [Related]  

  • 17. Warfarin dose requirement and CYP2C9 polymorphisms.
    Halkin H; Lubetsky A
    Lancet; 1999 Jun; 353(9168):1972-3. PubMed ID: 10371596
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative warfarin reversal for early hip fracture surgery.
    Moores TS; Beaven A; Cattell AE; Baker C; Roberts PJ
    J Orthop Surg (Hong Kong); 2015 Apr; 23(1):33-6. PubMed ID: 25920640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin resistance associated with intravenous lipid administration: discussion of propofol and review of the literature.
    MacLaren R; Wachsman BA; Swift DK; Kuhl DA
    Pharmacotherapy; 1997; 17(6):1331-7. PubMed ID: 9399621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary implications for patients receiving long-term oral anticoagulation therapy for treatment and prevention of thromboembolic disease.
    Kampouraki E; Kamali F
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):789-797. PubMed ID: 28635328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.